This study shows that the number of peripheral blood Foxp3+ Treg cells is significantly lower in clinically active as compared to remission RA patients while both demonstrate lower quantity than that of the healthy controls, which is in accordance with the other studies5. This evidence concerns the gene FOXP3 and rheumatoid arthritis.